Login
Toggle navigation
Videos
Categories
Trending
Subscribe for the latest updates in crypto, blockchain, and business news from NEW TO THE STREET!
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
John Lai is Pres/CEO/IR/Co-Founder, Petvivo Holdings Inc.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
ADT CEO Jim DeVries Talks Growth, Google Partnership, and Tech Future | Jim DeVries - Chairman of adt inc
00:10:00
Innovative Laser Keyboard Technology Showcased at CES 2014
00:10:00
Lenity Financial: Premier Investment and Financial Planning Services | Mark Bova, Co-Founders , Lenity Financial, Inc.
00:10:00
How to Calculate Inflation into Your Retirement Portfolio | Thomas J. Saunders, Managing Director, Winthrop Partners.
00:10:00
A Vision for the Future: Piers Bolger - Head of Infinity Asset Management
00:10:00
Navigating Market Ups and Downs: Mike Cintolo's Weekly Review | Mike Cintolo - market analyst and the editor of Cabot Market Letter
00:10:00
Making money is not worth anything if the firm had a rolercoster|Chad Byers,General Partner, Susa Ventures
00:10:00
VC is Primary’s Portfolio Impact team: Full-time, seasoned executives getting into the trenches|Ben Sun,Co-founding General Partner,Primary Venture Partners
00:10:00
Iron Ridge Resources: Advancing Gold and Lithium Projects Across Africa
00:10:00
TCW understands the complex investment needs of institutions and individuals. Through constantly changing financial markets, TCW prides itself on providing products and solutions designed to meet the investment objectives of our clients | Katie Koch,Presi
00:10:00
Keynote Address by Jennifer Morris: Strategies for Climate Action and Sustainability at Ohio State Earth Week Event
00:10:00
Expert Insights on Fiduciary Responsibility: An Interview with Craig Johnston